Drug Discovery And Development

4 researchers across 2 institutions

4 Researchers
2 Institutions
0 Grant PIs
1 High Impact

This research area investigates the identification, design, synthesis, and evaluation of new chemical entities with therapeutic potential. Investigations explore molecular mechanisms of disease to identify novel drug targets and employ organic synthesis and medicinal chemistry to create candidate molecules. Research also includes preclinical testing, assessing drug efficacy and safety through in vitro and in vivo models, and understanding drug metabolism and pharmacokinetics. Specific interests include the development of protein kinase inhibitors and the application of biocatalysis in drug synthesis.

Arkansas's agricultural heritage and biodiversity offer unique opportunities for drug discovery. Research explores the potential of natural products, derived from plants and microorganisms found within the state, as sources for novel therapeutic compounds. This work can contribute to the state's bioscience and pharmaceutical industries and address public health needs through the development of new treatments for diseases prevalent in the region.

This field draws upon expertise in molecular biology, organic chemistry, pharmacology, and genomics. Engagement spans multiple institutions across Arkansas, fostering a collaborative environment for advancing drug discovery and development.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Brendan Frett UAMS 24 1,408 High Impact
Irosha N. Nawarathne Lyon College 6 123
L.P.F. Balapiti-Modarage UAMS 2 189
Madeline Fulmer UAMS 1 2

Connected Research Areas

Topics that share active collaborators with Drug Discovery And Development in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
4,046 works in 2025
-3.0% CAGR 2018–2025
Leadership concentration
1.6% held by global top 5 institutions
Fragmented HHI 2
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 Science Exchange (United States) 648
  2. 2 University of Michigan 533
  3. 3 National Institutes of Health 474
  4. 4 Harvard University 459
  5. 5 University of Wisconsin–Madison 438

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Drug Discovery And Development.

Irosha N. Nawarathne Lyon College
32%
Irosha N. Nawarathne Lyon College
27%
Browse All 4 Researchers in Directory